Showing 1-10 of 23 grants

Title Institution Researcher Program Duration Total Award Amount
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 20-May-2026 $110,840.00
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 15-November-2026 $850,000.00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273,424.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare Nemours Children's Clinic Jessica Pierce Improving Lives 01-May-2023 to 30-April-2026 $628,819.87
Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation University of Florida Allison Bayer Cures 01-September-2023 to 31-March-2026 $510,297.39
Prohormone convertase activity in human T1D pancreas tissue slices University of Florida Denise Drotar Cures 01-March-2025 to 29-February-2028 $264,895.00
Tolerance signals from human pregnancy for beta cell replacement therapy University of Florida Edward Phelps Cures 01-December-2023 to 30-November-2025 $600,000.00
Evaluation of the safety, tolerability, and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D University of Florida Graciela Lorca Cures 01-September-2019 to 31-August-2026 $355,941.78